SCHEMBL15958746

SCHEMBL15958746

CCOc1ccc(CF)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.70
TSHR P16473 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
LTA4H P09960 2/20 0.52
SMN1; SMN2 Q16637 3/20 0.48
LMNA P02545 1/20 0.48
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
PARP10 Q53GL7 1/20 0.47
RELA Q04206 1/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
PRSS1 P07477 1/20 0.47
PRSS2 P07478 1/20 0.47
PRSS3 P35030 1/20 0.47
HRH3 Q9Y5N1 1/20 0.46
ADRA2A P08913 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15082057 0.84 LMNA (0.53) NQO1LTA4HLMNAALDH1A1CA12
1,4-Diethoxybenzene SCHEMBL124015 0.84 NQO1 (1.00) NQO1TSHRTDP1LTA4HSMN1; SMN2
1,4-Diethoxybenzene SCHEMBL28186701 0.84 NQO1 (1.00) NQO1TSHRTDP1LTA4HSMN1; SMN2
SCHEMBL2488793 0.82 NQO1 (0.74) NQO1TSHRTDP1LTA4HSMN1; SMN2
SCHEMBL14588243 0.82 NQO1 (0.74) NQO1TSHRTDP1LTA4HSMN1; SMN2
SCHEMBL31423 0.82 NQO1 (0.74) NQO1TSHRTDP1LTA4HSMN1; SMN2
1,4-Diethoxybenzene SCHEMBL11794798 0.81 NQO1 (0.93) NQO1TSHRTDP1LTA4HSMN1; SMN2
SCHEMBL5188545 0.80 NQO1 (0.70) NQO1TSHRTDP1LTA4HSMN1; SMN2
SCHEMBL9552950 0.79 CYP2D6 (0.59) LTA4HSMN1; SMN2LMNAKDM4EHRH3
1,4-Diethoxybenzene SCHEMBL27616183 0.78 NQO1 (0.88) NQO1TSHRTDP1LTA4HSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8969383-B2 Picolinamide derivatives as TTX-S blockers RAQUALIA PHARMA INC. (JP) 2015-03-03 US disclosed
US-20140296237-A1 PICOLINAMIDE DERIVATIVES AS TTX-S BLOCKERS RAQUALIA PHARMA INC (JP) 2014-10-02 US disclosed
US-8809380-B2 Picolinamide derivatives as TTX-S blockers RAQUALIA PHARMA INC. (JP) 2014-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296237-A1 PICOLINAMIDE DERIVATIVES AS TTX-S BLOCKERS CACNA1G, SCN3A, SCN5A NQO1 2150/4885TSHR 1285/4885TDP1 1478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.